P53-Induced Death Domain Protein (PIDD) (N-Term) Peptide
PIDD
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PIDD products
- PIDD (P53-Induced Death Domain Protein (PIDD))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LRDD antibody (Catalog #: ARP57269_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PIDD (P53-Induced Death Domain Protein (PIDD))
- Synonyms
- 1200011D09Rik Peptide, AU042446 Peptide, Pidd Peptide, LRDD Peptide, Lrdd Peptide, p53 induced death domain protein 1 Peptide, p53-induced death domain protein 1 Peptide, Pidd1 Peptide, PIDD1 Peptide
- Background
-
The protein encoded by this gene contains a leucine-rich repeat and a death domain. This protein has been shown to interact with other death domain proteins, such as Fas (TNFRSF6)-associated via death domain (FADD) and MAP-kinase activating death domain-c
Alias Symbols: DKFZp434D229, MGC16925, PIDD, LRDD
Protein Interaction Partner: CRADD,CASP2,CCDC85B,CRADD,EFEMP2,FADD,MADD,MDFI,CASP2,CCDC85B,CRADD,EFEMP2,FADD,MADD,MDFI
Protein Size: 753 - Molecular Weight
- 83 kDa
- Gene ID
- 55367
- NCBI Accession
- NM_018494, NP_060964
-
You are here:
